Kite Pharma, a subsidiary of Gilead Sciences, develops cancer immunotherapy products with a primary focus on genetically engineered autologous T cell therapy with chimeric antigen receptors.
Gloria HollifieldSenior Cell Therapy SpecialistGloria.hollifield@gilead.com8284426697
Chris Miller BS,MBAExecutive Cell Therapy SpecialistChris.miller@gilead.com3364087154
Brooks Penn Regional Director Brooks.penn@gilead.com9195234819
12:15-12:45 pm: Click here to join Kite's video meeting room. Password 726812
1:30-2:00 pm: Click here to join Kite's video meeting room. Password 077792
